esophagus cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. By pathological or cytological diagnosis of esophageal cancer patients; 2. Signed informed consent; 3. No radiotherapy, chemotherapy contraindications, and received chemotherapy; 4. Aged 18 to 80 years, physical condition score (ECOG 0 ~ 2 or KPS = 70); 5. Patients had good adherence to treatment and follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients who did not meet the criteria for pathology classification, staging, and survival status; 2. Not willing to accept chemotherapy patients; 3. Patients with uncontrolled hypertension, diabetes, unstable angina, history of myocardial infarction, or symptomatic congestive heart failure or uncontrolled arrhythmia during the last 12 months, disease activity in bacterial, fungal or viral infections, mental disorders; severe pulmonary dysfunction. 4. Pregnancy or breast-feeding patients; 5. Patients with a history of active malignancy other than esophageal cancer before inclusion, non-melanoma skin basal cell carcinoma, in situ cervical cancer, cured early prostate cancer; 6. With allergies and in patients with known or suspected allergy to any study drug without alternative medicines; 7. Poor compliance in patients; 8. The researchers believe that patients inadequacy participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival time;NRS;PG-SGA;treatment effect; | — |
Countries
China
Contacts
Affiliated hospital of Zunyi Medical University